Articles tagged with “NRX-101”
The FDA has authorized NRx Pharmaceuticals to offer NRX-101 combined with TMS for severe depression — here's what it means for the ketamine treatment landscape.
The FDA has cleared the MIND1 trial testing NRX-101 plus robotic TMS for suicidality in treatment-resistant depression. What it means for ketamine patients.
Send corrections, provider questions, or advertising inquiries.
